The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Site-selective modification strategies in antibody–drug conjugates
Open accessAbstract
Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an antibody to deliver a cytotoxic payload to specific cell types. This review summarises the advances made in the construction of homogenous ADCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Sletten, E. M., & Bertozzi, C. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900942 · Cited by 3,165
Agard, N. J., Prescher, J. A., & Bertozzi, C. R. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044996f · Cited by 3,017
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
Strategies and challenges for the next generation of antibody–drug conjugates
Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271
Heroux, J., & Gharib, A. M. (2008) · Molecular Imaging in Oncology · doi:10.3109/9781420019957-3 · Cited by 2,187
Adding New Chemistries to the Genetic Code
Liu, C. C., & Schultz, P. G. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.105824 · Cited by 1,725
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
Lewis Phillips, G. D., Li, G., Dugger, D. L., Crocker, L. M., Parsons, K. L., Mai, E., Blättler, W. A., Lambert, J. M., Chari, R. V. J., Lutz, R. J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1776 · Cited by 1,676
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0789 · Cited by 1,247
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt832 · Cited by 1,206
Inverse electron demand Diels–Alder reactions in chemical biology
Oliveira, B. L., Guo, Z., & Bernardes, G. J. L. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00184c · Cited by 1,139
(2013) · Elsevier eBooks · doi:10.1016/c2009-0-64240-9 · Cited by 1,139
Advances in Chemical Protein Modification
Boutureira, O., & Bernardes, G. J. L. (2015) · Chemical Reviews · doi:10.1021/cr500399p · Cited by 1,132
Transglutaminases: Nature’s biological glues
GRIFFIN, M., CASADIO, R., & BERGAMINI, C. M. (2002) · Biochemical Journal · doi:10.1042/bj20021234 · Cited by 1,042
Shen, B.-Q., Xu, K., Liu, L., Raab, H., Bhakta, S., Kenrick, M., Parsons-Reponte, K. L., Tien, J., Yu, S.-F., Mai, E., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2108 · Cited by 1,008
Selective chemical protein modification
Spicer, C. D., & Davis, B. G. (2014) · Nature Communications · doi:10.1038/ncomms5740 · Cited by 975
Sacituzumab govitecan-hziy in refractory metastatic triple-negative breast cancer
Bardia, A., Mayer, I. A., Vahdat, L. T., Tolaney, S. M., Isakoff, S. J., Diamond, J. R., O’Shaughnessy, J., Moroose, R. L., Santin, A. D., Abramson, V. G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814213 · Cited by 874
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
Antibody–Drug Conjugates: A Comprehensive Review
Khongorzul, P., Ling, C. J., Khan, F. U., Ihsan, A. U., & Zhang, J. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0582 · Cited by 787
A synthetic IgG-binding domain based on staphylococcal protein A
Nilsson, B., Moks, T., Jansson, B., Abrahmsén, L., Elmblad, A., Holmgren, E., Henrichson, C., Jones, T. A., & Uhlén, M. (1987) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/1.2.107 · Cited by 759
Expanding and reprogramming the genetic code
Chin, J. W. (2017) · Nature · doi:10.1038/nature24031 · Cited by 737
How Selenium Has Altered Our Understanding of the Genetic Code
Hatfield, D. L., & Gladyshev, V. N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3565-3576.2002 · Cited by 680
Krapp, S., Mimura, Y., Jefferis, R., Huber, R., & Sondermann, P. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01250-0 · Cited by 674
Cleavable linkers in antibody–drug conjugates
Bargh, J. D., Isidro-Llobet, A., Parker, J. S., & Spring, D. R. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00676h · Cited by 652
Self-citationAgarwal, P., & Bertozzi, C. R. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5004982 · Cited by 605
Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
Axup, J. Y., Bajjuri, K. M., Ritland, M., Hutchins, B. M., Kim, C. H., Kazane, S. A., Halder, R., Forsyth, J. S., Santidrian, A. F., Stafin, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211023109 · Cited by 596
Koniev, O., & Wagner, A. (2015) · Chem. Soc. Rev. · doi:10.1039/c5cs00048c · Cited by 594
Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Lyon, R. P., Bovee, T. D., Doronina, S. O., Burke, P. J., Hunter, J. H., Neff-LaFord, H. D., Jonas, M., Anderson, M. E., Setter, J. R., & Senter, P. D. (2015) · Nature Biotechnology · doi:10.1038/nbt.3212 · Cited by 557
Bioorthogonal Reactions for Labeling Proteins
Lang, K., & Chin, J. W. (2014) · ACS Chemical Biology · doi:10.1021/cb4009292 · Cited by 555
Contemporary approaches to site-selective protein modification
Hoyt, E. A., Cal, P. M. S. D., Oliveira, B. L., & Bernardes, G. J. L. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0079-1 · Cited by 537
Pučić, M., Knežević, A., Vidič, J., Adamczyk, B., Novokmet, M., Polašek, O., Gornik, O., Šupraha-Goreta, S., Wormald, M. R., Redžić, I., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010090 · Cited by 524
Bioconjugation with Maleimides: A Useful Tool for Chemical Biology
Ravasco, J. M. J. M., Faustino, H., Trindade, A., & Gois, P. M. P. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201803174 · Cited by 520
Strop, P., Liu, S.-H., Dorywalska, M., Delaria, K., Dushin, R. G., Tran, T.-T., Ho, W.-H., Farias, S., Casas, M. G., Abdiche, Y., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.01.010 · Cited by 505
Organometallic palladium reagents for cysteine bioconjugation
Vinogradova, E. V., Zhang, C., Spokoyny, A. M., Pentelute, B. L., & Buchwald, S. L. (2015) · Nature · doi:10.1038/nature15739 · Cited by 502
Liu, H., & May, K. (2012) · mAbs · doi:10.4161/mabs.4.1.18347 · Cited by 484
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
Alley, S. C., Benjamin, D. R., Jeffrey, S. C., Okeley, N. M., Meyer, D. L., Sanderson, R. J., & Senter, P. D. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004329 · Cited by 479
Physical and Chemical Studies on Ceruloplasmin
Morell, A. G., Irvine, R. A., Sternlieb, I., Scheinberg, I. H., & Ashwell, G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99337-3 · Cited by 476
Lyon, R. P., Setter, J. R., Bovee, T. D., Doronina, S. O., Hunter, J. H., Anderson, M. E., Balasubramanian, C. L., Duniho, S. M., Leiske, C. I., Li, F., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2968 · Cited by 461
Jain, N., Smith, S. W., Ghone, S., & Tomczuk, B. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1657-7 · Cited by 459
Long-Term Stabilization of Maleimide–Thiol Conjugates
Fontaine, S. D., Reid, R., Robinson, L., Ashley, G. W., & Santi, D. V. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5005262 · Cited by 427
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407
Fc glycans of therapeutic antibodies as critical quality attributes
Reusch, D., & Tejada, M. L. (2015) · Glycobiology · doi:10.1093/glycob/cwv065 · Cited by 404
Targeting the N terminus for site-selective protein modification
Rosen, C. B., & Francis, M. B. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2416 · Cited by 389
Analytical methods for physicochemical characterization of antibody drug conjugates
Wakankar, A., Chen, Y., Gokarn, Y., & Jacobson, F. S. (2011) · mAbs · doi:10.4161/mabs.3.2.14960 · Cited by 382
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
Smith, M. E. B., Schumacher, F. F., Ryan, C. P., Tedaldi, L. M., Papaioannou, D., Waksman, G., Caddick, S., & Baker, J. R. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908610s · Cited by 377
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
Sun, M. M. C., Beam, K. S., Cerveny, C. G., Hamblett, K. J., Blackmore, R. S., Torgov, M. Y., Handley, F. G. M., Ihle, N. C., Senter, P. D., & Alley, S. C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050201y · Cited by 370
Zimmerman, E. S., Heibeck, T. H., Gill, A., Li, X., Murray, C. J., Madlansacay, M. R., Tran, C., Uter, N. T., Yin, G., Rivers, P. J., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400490z · Cited by 363
Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon
Young, T. S., & Schultz, P. G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.091306 · Cited by 354
Antibody–PROTAC Conjugates Enable HER2-Dependent Targeted Protein Degradation of BRD4
Maneiro, M., Forte, N., Shchepinova, M. M., Kounde, C. S., Chudasama, V., Baker, J. R., & Tate, E. W. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00285 · Cited by 350
Site‐Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
Jeger, S., Zimmermann, K., Blanc, A., Grünberg, J., Honer, M., Hunziker, P., Struthers, H., & Schibli, R. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004243 · Cited by 344
The impact of glycosylation on monoclonal antibody conformation and stability
Zheng, K., Bantog, C., & Bayer, R. (2011) · mAbs · doi:10.4161/mabs.3.6.17922 · Cited by 342
Tamura, T., & Hamachi, I. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b11747 · Cited by 339
A general approach to site-specific antibody drug conjugates
Tian, F., Lu, Y., Manibusan, A., Sellers, A., Tran, H., Sun, Y., Phuong, T., Barnett, R., Hehli, B., Song, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321237111 · Cited by 319
Chemo- and Regioselective Lysine Modification on Native Proteins
Matos, M. J., Oliveira, B. L., Martínez-Sáez, N., Guerreiro, A., Cal, P. M. S. D., Bertoldo, J., Maneiro, M., Perkins, E., Howard, J., Deery, M. J., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b12874 · Cited by 314
Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions
Huang, W., Giddens, J., Fan, S.-Q., Toonstra, C., & Wang, L.-X. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3051266 · Cited by 308
Chemical cross‐linking with NHS esters: a systematic study on amino acid reactivities
Mädler, S., Bich, C., Touboul, D., & Zenobi, R. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1544 · Cited by 305
Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo
Labrijn, A. F., Buijsse, A. O., van den Bremer, E. T. J., Verwilligen, A. Y. W., Bleeker, W. K., Thorpe, S. J., Killestein, J., Polman, C. H., Aalberse, R. C., Schuurman, J., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1553 · Cited by 298
π-Clamp-mediated cysteine conjugation
Zhang, C., Welborn, M., Zhu, T., Yang, N. J., Santos, M. S., Van Voorhis, T., & Pentelute, B. L. (2016) · Nature Chemistry · doi:10.1038/nchem.2413 · Cited by 295
Sacituzumab Govitecan: First Approval
Syed, Y. Y. (2020) · Drugs · doi:10.1007/s40265-020-01337-5 · Cited by 293
Dennler, P., Chiotellis, A., Fischer, E., Brégeon, D., Belmant, C., Gauthier, L., Lhospice, F., Romagne, F., & Schibli, R. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400574z · Cited by 292
Junutula, J. R., Flagella, K. M., Graham, R. A., Parsons, K. L., Ha, E., Raab, H., Bhakta, S., Nguyen, T., Dugger, D. L., Li, G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0987 · Cited by 292
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
Badescu, G., Bryant, P., Bird, M., Henseleit, K., Swierkosz, J., Parekh, V., Tommasi, R., Pawlisz, E., Jurlewicz, K., Farys, M., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500148x · Cited by 290
Xenaki, K. T., Oliveira, S., & van Bergen en Henegouwen, P. M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01287 · Cited by 289
Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters
Kalkhof, S., & Sinz, A. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2231-5 · Cited by 282
van Geel, R., Wijdeven, M. A., Heesbeen, R., Verkade, J. M. M., Wasiel, A. A., van Berkel, S. S., & van Delft, F. L. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00224 · Cited by 279
Structural Comparison of Fucosylated and Nonfucosylated Fc Fragments of Human Immunoglobulin G1
Matsumiya, S., Yamaguchi, Y., Saito, J.-I., Nagano, M., Sasakawa, H., Otaki, S., Satoh, M., Shitara, K., & Kato, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.034 · Cited by 278
Sun, X., Ponte, J. F., Yoder, N. C., Laleau, R., Coccia, J., Lanieri, L., Qiu, Q., Wu, R., Hong, E., Bogalhas, M., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00062 · Cited by 277
Trastuzumab Deruxtecan: First Approval
Keam, S. J. (2020) · Drugs · doi:10.1007/s40265-020-01281-4 · Cited by 270
A Facile System for Encoding Unnatural Amino Acids in Mammalian Cells
Chen, P. R., Groff, D., Guo, J., Ou, W., Cellitti, S., Geierstanger, B. H., & Schultz, P. G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900683 · Cited by 269
Crystal Structure of Microbial Transglutaminase fromStreptoverticillium mobaraense
Kashiwagi, T., Yokoyama, K.-I., Ishikawa, K., Ono, K., Ejima, D., Matsui, H., & Suzuki, E.-I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203933200 · Cited by 264
Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum
Wuhrer, M., Stam, J. C., van de Geijn, F. E., Koeleman, C. A. M., Verrips, C. T., Dolhain, R. J. E. M., Hokke, C. H., & Deelder, A. M. (2007) · PROTEOMICS · doi:10.1002/pmic.200700289 · Cited by 263
Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies
Wang, W., Vlasak, J., Li, Y., Pristatsky, P., Fang, Y., Pittman, T., Roman, J., Wang, Y., Prueksaritanont, T., & Ionescu, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2010.12.009 · Cited by 257
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Maruani, A., Smith, M. E. B., Miranda, E., Chester, K. A., Chudasama, V., & Caddick, S. (2015) · Nature Communications · doi:10.1038/ncomms7645 · Cited by 256
Erickson, H. K., Widdison, W. C., Mayo, M. F., Whiteman, K., Audette, C., Wilhelm, S. D., & Singh, R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900315y · Cited by 246
Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment
McDonagh, C. F., Turcott, E., Westendorf, L., Webster, J. B., Alley, S. C., Kim, K., Andreyka, J., Stone, I., Hamblett, K. J., Francisco, J. A., et al. (2006) · Protein Engineering Design and Selection · doi:10.1093/protein/gzl013 · Cited by 243
Hinman, L. M., Hamann, P. R., Wallace, R., Menendez, A. T., Durr, F. E., & Upeslacis, J. (1993) · PubMed · Cited by 236
Beerli, R. R., Hell, T., Merkel, A. S., & Grawunder, U. (2015) · PLOS ONE · doi:10.1371/journal.pone.0131177 · Cited by 226
Anami, Y., Yamazaki, C. M., Xiong, W., Gui, X., Zhang, N., An, Z., & Tsuchikama, K. (2018) · Nature Communications · doi:10.1038/s41467-018-04982-3 · Cited by 226
Site-Specific Antibody–Drug Conjugation through Glycoengineering
Zhou, Q., Stefano, J. E., Manning, C., Kyazike, J., Chen, B., Gianolio, D. A., Park, A., Busch, M., Bird, J., Zheng, X., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400505q · Cited by 223
Polatuzumab Vedotin: First Global Approval
Deeks, E. D. (2019) · Drugs · doi:10.1007/s40265-019-01175-0 · Cited by 221
Hancock, S. M., Uprety, R., Deiters, A., & Chin, J. W. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104609m · Cited by 220
Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)
Uppal, H., Doudement, E., Mahapatra, K., Darbonne, W. C., Bumbaca, D., Shen, B.-Q., Du, X., Saad, O., Bowles, K., Olsen, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2093 · Cited by 218
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
Pillow, T. H., Adhikari, P., Blake, R. A., Chen, J., Del Rosario, G., Deshmukh, G., Figueroa, I., Gascoigne, K. E., Kamath, A. V., Kaufman, S., et al. (2020) · ChemMedChem · doi:10.1002/cmdc.201900497 · Cited by 216
Dorywalska, M., Dushin, R., Moine, L., Farias, S. E., Zhou, D., Navaratnam, T., Lui, V., Hasa-Moreno, A., Casas, M. G., Tran, T.-T., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-1004 · Cited by 216
Drake, P. M., Albers, A. E., Baker, J., Banas, S., Barfield, R. M., Bhat, A. S., de Hart, G. W., Garofalo, A. W., Holder, P., Jones, L. C., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500189z · Cited by 212
A common glycan structure on immunoglobulin G for enhancement of effector functions
Lin, C.-W., Tsai, M.-H., Li, S.-T., Tsai, T.-I., Chu, K.-C., Liu, Y.-C., Lai, M.-Y., Wu, C.-Y., Tseng, Y.-C., Shivatare, S. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513456112 · Cited by 200
Genetic Incorporation of Multiple Unnatural Amino Acids into Proteins in Mammalian Cells
Xiao, H., Chatterjee, A., Choi, S., Bajjuri, K. M., Sinha, S. C., & Schultz, P. G. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201308137 · Cited by 198
Inotuzumab Ozogamicin: First Global Approval
Lamb, Y. N. (2017) · Drugs · doi:10.1007/s40265-017-0802-5 · Cited by 198
Tumey, L. N., Charati, M., He, T., Sousa, E., Ma, D., Han, X., Clark, T., Casavant, J., Loganzo, F., Barletta, F., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500357n · Cited by 192
Bernardim, B., Cal, P. M. S. D., Matos, M. J., Oliveira, B. L., Martínez-Sáez, N., Albuquerque, I. S., Perkins, E., Corzana, F., Burtoloso, A. C. B., Jiménez-Osés, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms13128 · Cited by 188
Hoffmann, R. M., Coumbe, B. G. T., Josephs, D. H., Mele, S., Ilieva, K. M., Cheung, A., Tutt, A. N., Spicer, J. F., Thurston, D. E., Crescioli, S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1395127 · Cited by 188
Strop, P., Delaria, K., Foletti, D., Witt, J. M., Hasa-Moreno, A., Poulsen, K., Casas, M. G., Dorywalska, M., Farias, S., Pios, A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3274 · Cited by 182
Demonstration of a new amidase acting on glycopeptides
Takahashi, N. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90982-2 · Cited by 182
Antibody-Drug Conjugates: Possibilities and Challenges.
Nejadmoghaddam, M.-R., Minai‐Tehrani, A., Ghahremanzadeh, R., Mahmoudi, M., Dinarvand, R., & Zarnani, A. (2019) · Europe PMC (PubMed Central) · Cited by 182
Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates
Jeffrey, S. C., Andreyka, J. B., Bernhardt, S. X., Kissler, K. M., Kline, T., Lenox, J. S., Moser, R. F., Nguyen, M. T., Okeley, N. M., Stone, I. J., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600214 · Cited by 181
Primary structure of the Streptomyces enzyme endo-beta-N-acetylglucosaminidase H.
Robbins, P. W., Trimble, R. B., Wirth, D. F., Hering, C., Maley, F., Maley, G. F., Das, R., Gibson, B. W., Royal, N., & Biemann, K. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42829-8 · Cited by 177
Schumacher, F. F., Nunes, J. P. M., Maruani, A., Chudasama, V., Smith, M. E. B., Chester, K. A., Baker, J. R., & Caddick, S. (2014) · Org. Biomol. Chem. · doi:10.1039/c4ob01550a · Cited by 175
Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
Junutula, J. R., Bhakta, S., Raab, H., Ervin, K. E., Eigenbrot, C., Vandlen, R., Scheller, R. H., & Lowman, H. B. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.12.011 · Cited by 165
Behrens, C. R., Ha, E. H., Chinn, L. L., Bowers, S., Probst, G., Fitch-Bruhns, M., Monteon, J., Valdiosera, A., Bermudez, A., Liao-Chan, S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00432 · Cited by 162
Zeglis, B. M., Davis, C. B., Aggeler, R., Kang, H. C., Chen, A., Agnew, B. J., & Lewis, J. S. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400122c · Cited by 160
Agarwal, P., Kudirka, R., Albers, A. E., Barfield, R. M., de Hart, G. W., Drake, P. M., Jones, L. C., & Rabuka, D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400042a · Cited by 160
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
Yaghoubi, S., Karimi, M. H., Lotfinia, M., Gharibi, T., Mahi‐Birjand, M., Kavi, E., Hosseini, F., Sepehr, K. S., Khatami, M., Bagheri, N., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28967 · Cited by 155
Liu, H., Chumsae, C. M., Gaza‐Bulseco, G., Hurkmans, K., & Radziejewski, C. H. (2010) · Analytical Chemistry · doi:10.1021/ac100575n · Cited by 154
Effect of Attachment Site on Stability of Cleavable Antibody Drug Conjugates
Dorywalska, M., Strop, P., Melton-Witt, J. A., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5005747 · Cited by 153
Minireview: Addressing the retro-Michael instability of maleimide bioconjugates
Szijj, P. A., Bahou, C., & Chudasama, V. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.07.002 · Cited by 153
Yin, G., Garces, E. D., Yang, J., Zhang, J., Tran, C., Steiner, A. R., Roos, C. M., Bajad, S. U., Hudak, S. A., Penta, K., et al. (2012) · mAbs · doi:10.4161/mabs.4.2.19202 · Cited by 151
Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
Pillow, T. H., Sadowsky, J., Zhang, D., Yu, S., Rosario, G. D., Xu, K., He, J., Bhakta, S., Ohri, R. V., Kozak, K. R., et al. (2016) · Chemical Science · doi:10.1039/c6sc01831a · Cited by 145
VanBrunt, M. P., Shanebeck, K. D., Caldwell, Z., Johnson, J. E., Thompson, P., Martin, T., Dong, H., Li, G., Xu, H., D’Hooge, F., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00359 · Cited by 144
Kern, J. C., Cancilla, M. T., Dooney, D., Kwasnjuk, K., Zhang, R., Beaumont, M., Figueroa, I., Hsieh, S., Liang, L. A., Tomazela, D. M., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12547 · Cited by 143
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Parsons, T. B., Struwe, W. B., Gault, J., Yamamoto, K., Taylor, T. A., Raj, R., Wals, K., Mohammed, S., Robinson, C. V., Benesch, J. L. P., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201508723 · Cited by 143
Irvine, E. B., & Alter, G. (2020) · Glycobiology · doi:10.1093/glycob/cwaa018 · Cited by 143
Glycoengineering of Antibodies for Modulating Functions
Wang, L., Tong, X., Li, C., Giddens, J. P., & Li, T. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012911 · Cited by 141
Linker Technologies for Antibody–Drug Conjugates
Nolting, B. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-541-5_5 · Cited by 139
A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties
O'Shannessy, D. J., Dobersen, M. J., & Quarles, R. H. (1984) · Immunology Letters · doi:10.1016/0165-2478(84)90008-7 · Cited by 139
Adusumalli, S. R., Rawale, D. G., Singh, U., Tripathi, P., Paul, R., Kalra, N., Mishra, R. K., Shukla, S., & Rai, V. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10490 · Cited by 138
D’Amico, L., Menzel, U., Prummer, M., Müller, P., Buchi, M., Kashyap, A. S., Haessler, U., Yermanos, A., Gébleux, R., Briendl, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0464-1 · Cited by 136
Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides
Christie, R. J., Fleming, R. L., Bezabeh, B. Z., Woods, R., Mao, S., Harper, J. W., Joseph, A., Wang, Q., Xu, Z., Wu, H., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.032 · Cited by 132
Dunkelmann, D. L., Willis, J. C. W., Beattie, A. T., & Chin, J. W. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0472-x · Cited by 132
Site-Specific Protein Transamination Using N -Methylpyridinium-4-carboxaldehyde
Witus, L. S., Netirojjanakul, C., Palla, K. S., Muehl, E. M., Weng, C.-H., Iavarone, A. T., & Francis, M. B. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408868a · Cited by 128
Laguzza, B. C., Nichols, C. L., Briggs, S., et al. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00123a007 · Cited by 128
Casi, G., Huguenin‐Dezot, N., Zuberbühler, K., Scheuermann, J., & Neri, D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211589m · Cited by 128
Walsh, S. J., Omarjee, S., Galloway, W. R. J. D., Kwan, T. T.-L., Sore, H. F., Parker, J. S., Hyvönen, M., Carroll, J. S., & Spring, D. R. (2018) · Chemical Science · doi:10.1039/c8sc04645j · Cited by 128
Self-citationBryant, P., Pabst, M., Badescu, G. O., Bird, M., McDowell, W., Jamieson, E., Swierkosz, J., Jurlewicz, K., Tommasi, R., Henseleit, K. D., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00116 · Cited by 127
Li, T., Tong, X., Yang, Q., Giddens, J. P., & Wang, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738765 · Cited by 125
Ramakrishnan, B., Shah, P. S., & Qasba, P. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102458200 · Cited by 124
An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling.
Goodfellow, J., Baruah, K., Yamamoto, K., Bonomelli, C., Krishna, B., Harvey, D., Crispin, M., Scanlan, C. N., & Davis, B. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301334b · Cited by 123
AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies
Yamada, K., Shikida, N., Shimbo, K., Ito, Y., Khedri, Z., Matsuda, Y., & Mendelsohn, B. A. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814215 · Cited by 123
Jackson, D., Atkinson, J., Guevara, C. I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083865 · Cited by 122
Nunes, J. P. M., Morais, M., Vassileva, V., Robinson, E., Rajkumar, V. S., Smith, M. E. B., Pedley, R. B., Caddick, S., Baker, J. R., & Chudasama, V. (2015) · Chemical Communications · doi:10.1039/c5cc03557k · Cited by 121
Metabolic Engineering of Monoclonal Antibody Carbohydrates for Antibody–Drug Conjugation
Okeley, N. M., Toki, B. E., Zhang, X., Jeffrey, S. C., Burke, P., Alley, S. C., & Senter, P. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc4002695 · Cited by 120
Antibody–drug conjugates – a perfect synergy
Adair, J. R., Howard, P. W., Hartley, J. A., Williams, D. G., & Chester, K. A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.693473 · Cited by 120
Peck, M. C., Rothenberg, M. E., Deng, R., Lewin‐Koh, N., She, G., Kamath, A. V., Carrasco‐Triguero, M., Saad, O. M., Castro, A., Teufel, L. U., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02588-18 · Cited by 118
Cysteine‐Selective Phosphonamidate Electrophiles for Modular Protein Bioconjugations
Kasper, M., Glanz, M., Stengl, A., Penkert, M., Klenk, S., Sauer, T., Schumacher, D., Helma, J., Krause, E., Cardoso, M. C., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814715 · Cited by 115
Boeggeman, E. E., Ramakrishnan, B., Pasek, M., Manzoni, M., Puri, A., Loomis, K. H., Waybright, T. J., & Qasba, P. K. (2009) · Bioconjugate Chemistry · doi:10.1021/bc900103p · Cited by 114
Trastuzumab Emtansine: First Global Approval
Ballantyne, A. D., & Dhillon, S. (2013) · Drugs · doi:10.1007/s40265-013-0050-2 · Cited by 114
Lhospice, F., Brégeon, D., Belmant, C., Dennler, P., Chiotellis, A., Fischer, E., Gauthier, L., Boëdec, A., Rispaud, H., Savard-Chambard, S., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500666j · Cited by 112
Bromopyridazinedione-mediated protein and peptide bioconjugation
Chudasama, V., Smith, M. E. B., Schumacher, F. F., et al. (2011) · Chemical Communications · doi:10.1039/c1cc12807h · Cited by 110
Tang, F., Yang, Y., Tang, Y., Tang, S., Yang, L., Sun, B., Jiang, B., Dong, J., Liu, H., Huang, M., et al. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob01751g · Cited by 110
Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N -Propargyl Handles for Drug-Activation
Oliveira, B. L., Stenton, B. J., Unnikrishnan, V. B., de Almeida, C. R., Conde, J., Negrão, M., Schneider, F. S. S., CORDEIRO, C. A., Ferreira, M. G., Caramori, G. F., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01622 · Cited by 110
Ohri, R. V., Bhakta, S., Fourie-O’Donohue, A., Cruz-Chuh, J. D., Tsai, S. P., Cook, R., Wei, B. Q., Ng, C., Wong, A. W., Bos, A. B., et al. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00791 · Cited by 109
Nicolaou, K. C., & Rigol, S. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201903498 · Cited by 109
Sjögren, J., Struwe, W. B., Cosgrave, E. F. J., Rudd, P. M., Stervander, M., Allhorn, M., Hollands, A., Nizet, V., & Collin, M. (2013) · Biochemical Journal · doi:10.1042/bj20130126 · Cited by 108
Site‐Selective Cysteine–Cyclooctyne Conjugation
Zhang, C., Dai, P., Vinogradov, A. A., Gates, Z. P., & Pentelute, B. L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201800860 · Cited by 107
Li, F., Sutherland, M. K., Yu, C., Walter, R. B., Westendorf, L., Valliere‐Douglass, J. F., Pan, L. Y., Cronkite, A., Sussman, D. R., Klussman, K., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0742 · Cited by 106
Strop, P., Tran, T.-T., Dorywalska, M., Delaria, K., Dushin, R. G., Wong, O. K., Ho, W.-H., Zhou, D., Wu, A., Kraynov, E. A., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0431 · Cited by 105
Liu, C.-P., Tsai, T.-I., Cheng, T., Shivatare, V. S., Wu, C., Wu, C., & Wong, C. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718172115 · Cited by 105
Oller‐Salvia, B., Kym, G., & Chin, J. W. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712370 · Cited by 105
Molecularly Defined Antibody Conjugation through a Selenocysteine Interface
Höfer, T., Skeffington, L. R., Chapman, C. M., & Rader, C. M. (2009) · Biochemistry · doi:10.1021/bi901744t · Cited by 104
Zhu, Z., Ramakrishnan, B., Li, J., Wang, Y., Feng, Y., Prabakaran, P., Colantonio, S., Dyba, M., Qasba, P. K., & Dimitrov, D. S. (2014) · mAbs · doi:10.4161/mabs.29889 · Cited by 104
Chemoenzymatic Reversible Immobilization and Labeling of Proteins without Prior Purification
Rashidian, M., Song, J. M., Pricer, R. E., & Distefano, M. D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211308s · Cited by 103
Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates
Viricel, W., Fournet, G., Beaumel, S., Cros‐Perrial, E., Papot, S., Dumontet, C., & Joseph, B. (2019) · Chemical Science · doi:10.1039/c9sc00285e · Cited by 101
Physical and Chemical Stability of Antibody Drug Conjugates: Current Status
Ross, P. L., & Wolfe, J. L. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.037 · Cited by 100
Kurogochi, M., Mori, M., Osumi, K., Tojino, M., Sugawara, S.-I., Takashima, S., Hirose, Y., Tsukimura, W., Mizuno, M., Amano, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132848 · Cited by 99
Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
Jung, S. T., Kang, T. H., Kelton, W., & Georgiou, G. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.03.002 · Cited by 99
Wei, Y., Li, C., Huang, W., Li, B., Strome, S. E., & Wang, L. (2008) · Biochemistry · doi:10.1021/bi800874y · Cited by 99
Popp, B. V., & Ball, Z. T. (2011) · Chemical Science · doi:10.1039/c0sc00564a · Cited by 95
Giddens, J. P., Lomino, J. V., Amin, M. N., & Wang, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721597 · Cited by 95
Kern, J. C., Dooney, D., Zhang, R., Liang, L. A., Brandish, P. E., Cheng, M. M., Feng, G., Beck, A., Bresson, D., Firdos, J., et al. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00337 · Cited by 95
Bruins, J. J., Westphal, A. H., Albada, B., Wagner, K., Bartels, L., Spits, H., van Berkel, W. J. H., & van Delft, F. L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00046 · Cited by 94
Rader, C. M., Sinha, S. C., Popkov, M., Lerner, R. A., & Barbas, C. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931308100 · Cited by 93
Nanna, A. R., Li, X., Walseng, E., Pedzisa, L., Goydel, R. S., Hymel, D., Burke, T. R., Roush, W. R., & Rader, C. M. (2017) · Nature Communications · doi:10.1038/s41467-017-01257-1 · Cited by 93
Zuberbühler, K., Casi, G., Bernardes, G. J. L., & Neri, D. (2012) · Chemical Communications · doi:10.1039/c2cc32412a · Cited by 92
Novel peptide ligand with high binding capacity for antibody purification
Lund, L. N., Gustavsson, P., Roice, M., Lindgren, J., Nørskov‐Lauritsen, L., Lund, M., Houen, G., Staby, A., & Hilaire, P. M. S. (2011) · Journal of Chromatography A · doi:10.1016/j.chroma.2011.12.074 · Cited by 92
A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies
Ohata, J., & Ball, Z. T. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b06428 · Cited by 92
Upgrading aminoacyl-tRNA synthetases for genetic code expansion
Vargas-Rodriguez, O., Sevostyanova, A., Söll, D., & Crnković, A. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.07.014 · Cited by 92
Anami, Y., Xiong, W., Gui, X., Deng, M., Zhang, C. C., Zhang, N., An, Z., & Tsuchikama, K. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01027c · Cited by 90
Adusumalli, S. R., Rawale, D. G., Thakur, K., Purushottam, L., Reddy, N. C., Kalra, N., Shukla, S., & Rai, V. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202000062 · Cited by 90
Structure of the Murine Unglycosylated IgG1 Fc Fragment
Feige, M. J., Nath, S., Catharino, S., Weinfurtner, D., Steinbacher, S., & Büchner, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.048 · Cited by 89
Next-generation disulfide stapling: reduction and functional re-bridging all in one
Lee, M. T. W., Maruani, A., Baker, J. R., Caddick, S., & Chudasama, V. (2015) · Chemical Science · doi:10.1039/c5sc02666k · Cited by 88
De Novo Generation of Mutually Orthogonal Aminoacyl-tRNA Synthetase/tRNA Pairs
Neumann, H., Slusarczyk, A. L., & Chin, J. W. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9068722 · Cited by 88
N-Glycans Modulate the Function of Human Corticosteroid-Binding Globulin
Sumer‐Bayraktar, Z., Kolarich, D., Campbell, M. P., Ali, S. O., Packer, N. H., & Thaysen‐Andersen, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.009100 · Cited by 87
King, G. T., Eaton, K. D., Beagle, B. R., Zopf, C. J., Wong, G. Y., Krupka, H. I., Hua, S. Y., Messersmith, W. A., & El-Khoueiry, A. B. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0560-6 · Cited by 87
Lee, J., Choi, H., Yun, M., Kang, Y. J., Jung, J., Ryu, Y., Kim, T. Y., Cha, Y., Cho, H., Min, J., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505964 · Cited by 86
Zeglis, B. M., Davis, C. B., Abdel-Atti, D., Carlin, S., Chen, A., Aggeler, R. J., Agnew, B. J., & Lewis, J. S. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500499h · Cited by 85
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma
Richardson, N. C., Kasamon, Y. L., Chen, H., de Claro, R. A., Ye, J., Blumenthal, G. M., Farrell, A. T., & Pazdur, R. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0098 · Cited by 85
Stefan, N., Gébleux, R., Waldmeier, L., Hell, T., Escher, M., Wolter, F. I., Grawunder, U., & Beerli, R. R. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0688 · Cited by 82
Kishimoto, S., Nakashimada, Y., Yokota, R., Hatanaka, T., Adachi, M., & Ito, Y. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00865 · Cited by 81
Bahou, C., Richards, D. A., Maruani, A., Love, E. A., Javaid, F., Caddick, S., Baker, J. R., & Chudasama, V. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob03138f · Cited by 80
Barok, M., Joncour, V. L., Martins, A., Isola, J. J., Salmikangas, M., Laakkonen, P., & Joensuu, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.037 · Cited by 80
Sulfatase-cleavable linkers for antibody-drug conjugates
Bargh, J. D., Walsh, S. J., Isidro‐Llobet, A., Omarjee, S., Carroll, J. S., & Spring, D. R. (2020) · Chemical Science · doi:10.1039/c9sc06410a · Cited by 80
Self-citationEthynylation of Cysteine Residues: From Peptides to Proteins in Vitro and in Living Cells
Tessier, R., Nandi, R. K., Dwyer, B. G., Abegg, D., Sornay, C., Ceballos, J., Erb, S., Cianférani, S., Wagner, A., Chaubet, G., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002626 · Cited by 79
Robinson, E., Nunes, J. P. M., Vassileva, V., Maruani, A., Nogueira, J. C. F., Smith, M. E. B., Pedley, R. B., Caddick, S., Baker, J. R., & Chudasama, V. (2017) · RSC Advances · doi:10.1039/c7ra00788d · Cited by 78
Efficient Preparation of Site-Specific Antibody–Drug Conjugates Using Cysteine Insertion
Dimasi, N., Fleming, R. L., Zhong, H., Bezabeh, B. Z., Kinneer, K., Christie, R. J., Fazenbaker, C. A., Wu, H., & Gao, C. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00995 · Cited by 76
Vinylphosphonites for Staudinger-induced chemoselective peptide cyclization and functionalization
Kasper, M., Glanz, M., Oder, A., Schmieder, P., von Kries, J. P., & Hackenberger, C. P. R. (2019) · Chemical Science · doi:10.1039/c9sc01345h · Cited by 76
Wilbur, D. S., Chyan, M., Nakamae, H., Chen, Y., Hamlin, D. K., Santos, E. B., Kornblit, B. T., & Sandmaier, B. M. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200401b · Cited by 75
An engineered selenocysteine defines a unique class of antibody derivatives
Höfer, T., Thomas, J. D., Burke, T. R., & Rader, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800800105 · Cited by 75
Morais, M., Nunes, J. P. M., Karu, K., Forte, N., Benni, I., Smith, M. E. B., Caddick, S., Chudasama, V., & Baker, J. R. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob00220c · Cited by 75
Genetic code expansion for multiprotein complex engineering
Koehler, C., Sauter, P. F., Wawryszyn, M., Girona, G. E., Gupta, K., Landry, J. J. M., Fritz, M. H.-Y., Radić, K., Hoffmann, J., Chen, Z. A., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4032 · Cited by 74
Tumey, L. N., Li, F., Rago, B., Han, X., Loganzo, F., Musto, S., Graziani, E. I., Puthenveetil, S., Casavant, J. M., Marquette, K., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0083-7 · Cited by 74
Proximity-Induced Site-Specific Antibody Conjugation
Yu, C., Tang, J., Loredo, A., Chen, Y., Jung, S. Y., Jain, A., Gordon, A., & Xiao, H. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00680 · Cited by 74
Kudirka, R. A., Barfield, R. M., McFarland, J. M., Albers, A. E., de Hart, G. W., Drake, P. M., Holder, P. G., Bañas, S., Jones, L. C., Garofalo, A. W., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.11.019 · Cited by 73
Kolodych, S., Koniev, O., Baatarkhuu, Z., Bonnefoy, J., Debaene, F., Cianférani, S., DORSSELAER, A. V., & Wagner, A. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500610g · Cited by 73
Matos, M. J., Navo, C. D., Hakala, T. A., Ferhati, X., Guerreiro, A., Hartmann, D., Bernardim, B., Saar, K. L., Compañón, I., Corzana, F., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901405 · Cited by 72
Kumar, A., Kinneer, K., Masterson, L. A., Ezeadi, E., Howard, P. W., Wu, H., Gao, C., & Dimasi, N. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.10.043 · Cited by 71
Evolved sequence contexts for highly efficient amber suppression with noncanonical amino acids.
Pott, M., Schmidt, M., & Summerer, D. (2014) · ACS Chemical Biology · doi:10.1021/cb5006273 · Cited by 70
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate
Lim, R. K. V., Yu, S., Cheng, B., Li, S., Kim, N., Cao, Y. J., Chi, V., Kim, J. Y., Chatterjee, A. K., Schultz, P. G., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00203 · Cited by 70
Kasper, M., Stengl, A., Ochtrop, P., Gerlach, M., Stoschek, T., Schumacher, D., Helma, J., Penkert, M., Krause, E., Leonhardt, H., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904193 · Cited by 70
Antibodies and associates: Partners in targeted drug delivery
Kennedy, P. J., Oliveíra, C., Granja, P. L., & Sarmento, B. F. C. C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.004 · Cited by 69
Cited by
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
Nguyen, T. D., Bordeau, B. M., & Balthasar, J. P. (2023) · Cancers · doi:10.3390/cancers15030713 · Cited by 441
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
Tong, J. T. W., Harris, P. W. R., Brimble, M. A., & Kavianinia, I. (2021) · Molecules · doi:10.3390/molecules26195847 · Cited by 287
Designing antibodies as therapeutics
Carter, P. J., & Rajpal, A. (2022) · Cell · doi:10.1016/j.cell.2022.05.029 · Cited by 267
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Colombo, R., Tarantino, P., Rich, J. R., LoRusso, P. M., & de Vries, E. G. E. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0708 · Cited by 254
Metadata
- Authors
- Walsh, S. J., Bargh, J. D., Dannheim, F. M., Hanby, A. R., Seki, H., Counsell, A. J., Ou, X., Fowler, E., Ashman, N., Takada, Y., Isidro-Llobet, A., Parker, J. S., Carroll, J. S., & Spring, D. R.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 50
- Issue
- 2
- Pages
- 1305-1353
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W3111378088
- Cited by
- 461
- References
- 291
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.